Serum CA125 Level Is Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes

References

• Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124–136. doi:10.1016/S0140-6736(09)62124-3
   PubMed Web of Science ®Google Scholar
• Stitt AW, Curtis TM, Chen M, et al. The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res. 2016;51:156–186. doi:10.1016/j.preteyeres.2015.08.001
   PubMed Web of Science ®Google Scholar
• Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350(1):48–58. doi:10.1056/NEJMra021678
   PubMed Web of Science ®Google Scholar
• Kempen JH, O’Colmain BJ, Leske MC, et al. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552–563.
   PubMed Web of Science ®Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564. doi:10.2337/dc11-1909
   PubMed Web of Science ®Google Scholar
• Nathan DM, Genuth S, Lachin J, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986.
   PubMed Web of Science ®Google Scholar
• Wong TY, Cheung CMG, Larsen M, Sharma S, Simó R. Diabetic retinopathy. Nat Rev Dis Primers. 2016;2:16012. doi:10.1038/nrdp.2016.12
   PubMed Web of Science ®Google Scholar
• Ferris FL. How effective are treatments for diabetic retinopathy? JAMA. 1993;269(10):1290–1291. doi:10.1001/jama.1993.03500100088034
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes–2014. Diabetes Care. 2014;37(Suppl 1):S14–S80. doi:10.2337/dc14-S014
   PubMed Web of Science ®Google Scholar
• Shlomai G, Neel B, LeRoith D, Gallagher EJ. Type 2 diabetes mellitus and cancer: the role of pharmacotherapy. J Clin Oncol. 2016;34(35):4261–4269. doi:10.1200/JCO.2016.67.4044
   PubMed Web of Science ®Google Scholar
• Badrick E, Renehan AG. Diabetes and cancer: 5 years into the recent controversy. Eur J Cancer. 2014;50(12):2119–2125.
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33(7):1674–1685. doi:10.2337/dc10-0666
   PubMed Web of Science ®Google Scholar
• Azuma S, Asahina Y, Kakinuma S, et al. Diabetic retinopathy as a risk factor associated with the development of hepatocellular carcinoma in nonalcoholic fatty liver disease. Dig Dis. 2019;37(3):247–254. doi:10.1159/000493580
   PubMedGoogle Scholar
• Sturgeon C. Practice guidelines for tumor marker use in the clinic. Clin Chem. 2002;48(8):1151–1159. doi:10.1093/clinchem/48.8.1151
   PubMedGoogle Scholar
• Yu C, Lei Q, Wang J, et al. Serum carbohydrate antigen 125 levels and incident risk of type 2 diabetes mellitus in middle-aged and elderly Chinese population: the Dongfeng-Tongji cohort study. Diab Vasc Dis Res. 2019;16(5):424–430. doi:10.1177/1479164119843095
   PubMedGoogle Scholar
• Diamandis EP, Bast RC, Gold P, Chu TM, Magnani JL. Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9. Clin Chem. 2013;59(1):22–31. doi:10.1373/clinchem.2012.187047
   PubMedGoogle Scholar
• Esteghamati A, Seyedahmadinejad S, Zandieh A, et al. The inverse relation of CA-125 to diabetes, metabolic syndrome, and associated clinical variables. Metab Syndr Relat Disord. 2013;11(4):256–261. doi:10.1089/met.2012.0058
   PubMedGoogle Scholar
• Xie XY, Zhong RH. The relationship between serum tumor biomarker levels and complication of diabetes patients. Chin J Health Lab Technol. 2015;25:1005–1007.
   Google Scholar
• Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs–an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98(5 Suppl):786–806. doi:10.1016/S0161-6420(13)38012-9
   PubMedGoogle Scholar
• Sasongko MB, Widyaputri F, Agni AN, et al. Prevalence of diabetic retinopathy and blindness in Indonesian adults with type 2 diabetes. Am J Ophthalmol. 2017;181:79–87. doi:10.1016/j.ajo.2017.06.019
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102(4):527–532. doi:10.1001/archopht.1984.01040030405011
   PubMed Web of Science ®Google Scholar
• Song P, Yu J, Chan KY, Theodoratou E, Rudan I. Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis. J Glob Health. 2018;8(1):010803. doi:10.7189/jogh.08.010803
   PubMed Web of Science ®Google Scholar
• Silidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ (Clinical Research Ed). 2015;350:g7607.
   PubMedGoogle Scholar
• Hwangbo Y, Kang D, Kang M, et al. Incidence of diabetes after cancer development: a Korean National Cohort Study. JAMA Oncol. 2018;4(8):1099–1105. doi:10.1001/jamaoncol.2018.1684
   PubMed Web of Science ®Google Scholar
• Oubaha M, Miloudi K, Dejda A, et al. Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy. Sci Transl Med. 2016;8(362):362ra144. doi:10.1126/scitranslmed.aaf9440
   PubMed Web of Science ®Google Scholar
• Falcao F, de Oliveira FRA, da Silva M, Sobral Filho DC. Carbohydrate antigen 125: a promising tool for risk stratification in heart diseases. Biomark Med. 2018;12(4):367–381. doi:10.2217/bmm-2017-0452
   PubMedGoogle Scholar
• Huang F, Chen J, Liu Y, Zhang K, Wang J, Huang H. New mechanism of elevated CA125 in heart failure: the mechanical stress and inflammatory stimuli initiate CA125 synthesis. Med Hypotheses. 2012;79(3):381–383. doi:10.1016/j.mehy.2012.05.042
   PubMedGoogle Scholar
• Akinwunmi BO, Babic A, Vitonis AF, Cramer DW, Titus L, Tworoger SS. Chronic medical conditions and CA125 levels among women without ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2018;27(12):1483–1490.
   PubMed Web of Science ®Google Scholar
• De Gennaro L, Brunetti ND, Montrone D, De Rosa F, Cuculo A, Di Biase M. Inflammatory activation and carbohydrate antigen-125 levels in subjects with atrial fibrillation. Eur J Clin Invest. 2012;42(4):371–375. doi:10.1111/j.1365-2362.2011.02592.x
   PubMedGoogle Scholar
• Li J, Song SJ, Liu FL, et al. Carbohydrate antigen 125 levels and clinical outcomes after off-pump coronary artery bypass grafting. Coron Artery Dis. 2015;26(5):432–436. doi:10.1097/MCA.0000000000000262
   PubMedGoogle Scholar